NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $282,658 | -18.0% | 4,700 | 0.0% | 0.02% | -20.8% |
| Q4 2022 | $344,745 | -3.4% | 4,700 | 0.0% | 0.02% | -11.1% |
| Q3 2022 | $357,000 | +9.2% | 4,700 | 0.0% | 0.03% | +12.5% |
| Q2 2022 | $327,000 | -30.7% | 4,700 | -17.5% | 0.02% | -17.2% |
| Q1 2022 | $472,000 | -11.4% | 5,700 | -19.7% | 0.03% | -14.7% |
| Q4 2021 | $533,000 | -35.4% | 7,100 | 0.0% | 0.03% | -37.0% |
| Q3 2021 | $825,000 | -20.9% | 7,100 | +51.1% | 0.05% | -19.4% |
| Q2 2021 | $1,043,000 | +68.0% | 4,700 | 0.0% | 0.07% | +45.7% |
| Q1 2021 | $621,000 | -23.6% | 4,700 | 0.0% | 0.05% | -28.1% |
| Q4 2020 | $813,000 | +55.4% | 4,700 | 0.0% | 0.06% | +36.2% |
| Q3 2020 | $523,000 | – | 4,700 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $29,071,000 | 12.94% |
| HARTLINE INVESTMENT CORP/ | 302,194 | $67,033,000 | 8.47% |
| Deep Track Capital, LP | 1,000,000 | $82,850,000 | 5.31% |
| MORGAN JESS S & CO INC | 48,860 | $4,048,000 | 2.94% |
| Taylor Frigon Capital Management LLC | 73,014 | $6,049,000 | 2.24% |
| Private Harbour Investment Management & Counsel, LLC | 13,263 | $1,099,000 | 0.92% |
| HighVista Strategies LLC | 17,448 | $1,446,000 | 0.92% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $829,000 | 0.79% |
| Lloyd Park, LLC | 6,700 | $555,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 69,700 | $5,775,000 | 0.57% |